Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Nava Therapeutics has launched with $89 million in funding to advance a lipid nanoparticle platform intended to deliver RNA medicines beyond the liver, with initial programs significantly focused on i...
The US Food and Drug Administration (FDA) has advised infant formula producers to tighten supplier oversight after botulism outbursts and a contaminated ingredient triggered recalls in multiple market...
Cytovance Biologics, an important US-based contract development and manufacturing organization (CDMO) helping the pharmaceutical organization, announced the expansion of its upstream process advanceme...
Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted government support to its collaboration partner, Zenara Pharma, to produce a Syntheti...
Evonik is making a noteworthy investment to support production abilities at its Lafayette, Indiana, facility. After completing the next five years, the organization will spend US$100 million to modern...
Givaudan, the worldwide leader in fragrance and beauty, announced an equity spending and strategic partnering with the Swiss organization Microcaps AG to strengthen its encapsulation capabilities, rei...
SpudCell is the first artificial cell that can feed, grow, and achieve an entire life cycle. It is made entirely of non-living chemical mechanisms, marking a significant step for synthetic biology, ba...
Inside Therapeutics partners with Meiwafosis Co., Ltd. to bring microfluidic nanoparticle formulation technology to scientists in the country, backed by a distributor who knows the local research land...
Peer-Reviewed Studies Confirm Strong Clinical Performance Biocon announced the publication of important clinical data supporting the effectiveness of Yesafili, its biosimilar version of Eylea (aflibe...
Healthcare Entrepreneur Plans a New Phase of Expansion On 12th July 2026, Indian healthcare entrepreneur GSK Velu is preparing for a major milestone in his business journey by planning to list four o...
Speak with a healthcare analyst about your research, consulting, or platform needs.